Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model

PURPOSE: Inhaled triple therapy (TT) comprising a long-acting muscarinic antagonist, long-acting β(2) agonist, and inhaled corticosteroid is recommended for symptomatic chronic obstructive pulmonary disease (COPD) patients, or those at risk of exacerbation. However, it is not well understood which p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogart, Michael, Liu, Yuhang, Oakland, Todd, Stiegler, Marjorie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995152/
https://www.ncbi.nlm.nih.gov/pubmed/35418750
http://dx.doi.org/10.2147/COPD.S336297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995152/
https://www.ncbi.nlm.nih.gov/pubmed/35418750
http://dx.doi.org/10.2147/COPD.S336297

Ejemplares similares